NCT03395756View on ClinicalTrials.gov

Depot Medroxyprogesterone Acetate as Emergency Contraception

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2018

Primary Completion Date

October 30, 2020

Study Completion Date

October 30, 2020

Conditions
Emergency ContraceptionContraception
Interventions
DRUG

Depot-Medroxyprogestereone Acetate

Administration of 150 mg intramuscular depot medroxyprogesterone acetate

Trial Locations (1)

90033

University of Southern California Keck Medical Center, Los Angeles

All Listed Sponsors
collaborator

Society of Family Planning

OTHER

lead

University of Southern California

OTHER

NCT03395756 - Depot Medroxyprogesterone Acetate as Emergency Contraception | Biotech Hunter | Biotech Hunter